Rosuvastatin EP Impurity C(Calcium Salt) CAS 1422514-05-3
| CAS No. | 1422514-05-3 |
| Molecular Formula | 2*C22H25FN3O6S |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Rosuvastatin EP Impurity C(Calcium Salt) is closely related to a flavonoid core, an amide group, a sulfone group, a hydroxyl group, an ether linkage, fluorine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
Rosuvastatin EP Impurity C(Calcium Salt) (CAS 1422514-05-3) is a certified pharmaceutical impurity reference standard with the molecular formula C22H25FN3O6SCa and a molecular weight of 518.59 g/mol.
The molecular framework of Rosuvastatin EP Impurity C(Calcium Salt) (C22H25FN3O6SCa) is characterized by a flavonoid core, an amide group, a sulfone group, a hydroxyl group, an ether linkage, fluorine substitution. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | 2*C22H25FN3O6S Ca |
| Molecular Weight | 518.59 g/mol |
| Purity | >95% |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 11.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1991 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 3 |
| Sulfur Atoms | 1 |
Related Rosuvastatin Standards
- Rosuvastatin Impurity 205 (CAS 1007871-85-3)
- Rosuvastatin EP Impurity L Calcium(Mixture of Diastereomers) (CAS 1024064-70-7)
- Rosuvastatin Impurity 267 (CAS 1031246-43-1)
- Rosuvastatin Impurity 19 (CAS 1035595-71-1)
- Rosuvastatin Impurity 27 (CAS 1044518-75-3)
- Rosuvastatin Impurity 192 (CAS 1092844-00-2)
- Rosuvastatin Impurity 123 (CAS 1112048-62-0)
- Rosuvastatin Impurity 37 (CAS 1197348-98-3)
Recommended Standards
- Finerenone Impurity 13 (CAS 1050477-45-6)
- Betamethasone Impurity 113 (CAS CATO-C4X-1437113)
- Citalopram Impurity 21 Oxalate (CAS 1433278-32-0(free base))
- 2-Bromo-N-(4-chlorophenyl)-2,2-difluoroacetamide (CAS 1949728-29-3)
- 4-(3-Methoxybenzyl)tetrahydro-2h-thiopyran-4-carboxylic acid 1,1-dioxide (CAS 1993099-15-2)
- Methyl 5-((4-chlorophenoxy)methyl)furan-2-carboxylate (CAS 406470-68-6)
- (S)-tert-butyl 3-((2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(3-hydroxy-3-methylbut-1-ynyl)-1H-imidazo[4,5-c]pyridin-7-yloxy)methyl)piperidine-1-carboxylate (CAS 937174-75-9)
- 7-Nitrobenzofuran-3(2H)-one (CAS 164915-57-5)
- 2-bromo-1-[4-(bromomethyl)phenyl]ethan-1-one (CAS 62546-51-4)
- C-Peptide (human) (CAS 33017-11-7)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com